The prognostic role of the neutrophil-to-lymphocyte ratio in oropharyngeal carcinoma treated with chemoradiotherapy

Clinical Medicine Insights: Oncology

Volumn 8, Issue , 2014, Pages 81-86

  Young, Caroline A ^a   Murray, Louise J ^a   Karakaya, Ebru ^a   Thygesen, Helene H ^b   Sen, Mehmet ^a   Prestwich, Robin J D ^a  

^a St James's Institute of Oncology   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Chemotherapy; Neutrophil to lymphocyte ratio; Oropharynx cancer; Radiotherapy; Squamous cell cancer

Indexed keywords

CISPLATIN; DOCETAXEL; FLUOROURACIL;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER GRADING; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CHEMORADIOTHERAPY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NEUTROPHIL TO LYMPHOCYTE RATIO; ONCOLOGICAL PARAMETERS; OROPHARYNX CARCINOMA; OVERALL SURVIVAL; PLATELET TO LYMPHOCYTE RATIO; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

EID: 84903640079     PISSN: None     EISSN: 11795549     Source Type: Journal    
DOI: 10.4137/CMO.s15476     Document Type: Article

References (28)

1. Ramos M, Benavente S, Giralt J. Management of squamous cell carcinoma of the head and neck: updated European treatment recommendations. Expert Rev Anticancer Ter. 2010;10(3):339-344.
2. Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010;363(1): 24-35.
3. Machtay M, Moughan J, Trotti A, et al. Factors associated with severe late toxic-ity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol. 2008;26(21):3582-3589.
4. Roxburgh CS, McMillan DC. Role of systemic infammatory response in predicting survival in patients with primary operable cancer. Future Oncol. 2010;6(1):149-163.
5. Guthrie GJ, Charles KA, Roxburgh CS, Horgan PG, McMillan DC, Clarke SJ. Te systemic infammation-based neutrophil-lymphocyte ratio: experience in patients with cancer. Crit Rev Oncol Hematol. 2013;88(1):218-230.
6. McMillan DC. Systemic infammation, nutritional status and survival in patients with cancer. Curr Opin Clin Nutr Metab Care. 2009;12(3):223-226.
7. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to infammation. N Engl J Med. 1999;340(6):448-454.
8. Proctor MJ, Morrison DS, Talwar D, et al. A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study. Eur J Cancer. 2011;47(17):2633-2641.
9. Proctor MJ, McMillan DC, Morrison DS, Fletcher CD, Horgan PG, Clarke SJ. A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer. Br J Cancer. 2012;107(4):695-699.
10. Proctor MJ, Horgan PG, Talwar D, Fletcher CD, Morrison DS, McMillan DC. Optimization of the systemic inflammation-based Glasgow prognostic score: a Glasgow Inflammation Outcome Study. Cancer. 2013;119(12):2325-2322.
11. Szkandera J, Pichler M, Absenger G, et al. Te elevated preoperative platelet to lymphocyte ratio predicts decreased time to recurrence in colon cancer patients. Am J Surg. 2014. pii: S0002-9610(14)000 43-9. doi: 10.1016/j.amjsurg. 2013.10.030. [Epub ahead of print].
12. Rassouli A, Saliba J, Castano R, Hier M, Zeitouni AG. Systemic inflammatory markers as independent prognosticators of head and neck squamous cell carcinoma. Head Neck. December 13, 2013. doi: 10.1002/hed.23567. [Epub ahead of print].
13. Prestwich RJ, Kancherla K, Oksuz DC, et al. A single centre experience with sequential and concomitant chemoradiotherapy in locally advanced stage IV ton-sillar cancer. Radiat Oncol. 2010;5:121.
14. Prestwich RJ, Oksuz DC, Dyker K, Coyle C, Sen M. Feasibility and efficacy of induction docetaxel, cisplatin, and 5-fuorouracil chemotherapy combined with cisplatin concurrent chemoradiotherapy for nonmetastatic stage IV head-and-neck squamous cell carcinomas. Int J Radiat Oncol Biol Phys. 2011;81(4):e237-e243.
15. Nutting CM, Morden JP, Harrington KJ, et al. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PAR-SPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol. 2011;12(2):127-136.
16. Azab B, Bhatt VR, Phookan J, et al. Usefulness of the neutrophil-to-lymphocyte ratio in predicting short- and long-term mortality in breast cancer patients. Ann Surg Oncol. 2012;19(1):217-224.
17. Ubukata H, Motohashi G, Tabuchi T, Nagata H, Konishi S. Evaluations of interferon-gamma/interleukin-4 ratio and neutrophil/lymphocyte ratio as prognostic indicators in gastric cancer patients. J Surg Oncol. 2010;102(7):742-747.
18. Sato H, Tsubosa Y, Kawano T. Correlation between the pretherapeutic neutrophil to lymphocyte ratio and the pathologic response to neoadjuvant chemotherapy in patients with advanced esophageal cancer. World J Surg. 2012;36(3):617-622.
19. Chua W, Clarke SJ, Charles KA. Systemic inflammation and prediction of chemotherapy outcomes in patients receiving docetaxel for advanced cancer. Support Care Cancer. 2012;20(8):1869-1874.
20. Clarke SJ, Chua W, Moore M, et al. Use of inflammatory markers to guide cancer treatment. Clin Pharmacol Ter. 2011;90(3):475-478.
21. Kwon HC, Kim SH, Oh SY, et al. Clinical significance of preoperative neutrophil-lymphocyte versus platelet-lymphocyte ratio in patients with operable colorectal cancer. Biomarkers. 2012;17(3):216-222.
22. He JR, Shen GP, Ren ZF, et al. Pretreatment levels of peripheral neutrophils and lymphocytes as independent prognostic factors in patients with nasopharyngeal carcinoma. Head Neck. 2012;34(12):1769-1776.
23. Millrud CR, Mansson Kvarnhammar A, Uddman R, Bjornsson S, Riesbeck K, Cardell LO. Te activation pattern of blood leukocytes in head and neck squamous cell carcinoma is correlated to survival. PLoS One. 2012;7(12):e51120.
24. Chen HH, Chen IH, Liao CT, Wei FC, Lee LY, Huang SF. Preoperative circulating C-reactive protein levels predict pathological aggressiveness in oral squamous cell carcinoma: a retrospective clinical study. Clin Otolaryngol. 2011;36(2):147-153.
25. Motomura T, Shirabe K, Mano Y, et al. Neutrophil-lymphocyte ratio refects hepatocellular carcinoma recurrence after liver transplantation via infammatory microenvironment. J Hepatol. 2013;58(1):58-64.
26. Kantola T, Klintrup K, Vayrynen J P, et al. Stage-dependent alterations of the serum cytokine pattern in colorectal carcinoma. Br J Cancer. 2012;107(10):1729-1736.
27. Ward MJ, Tirdborough SM, Mellows T, et al. Tumour-infltrating lymphocytes predict for outcome in HPV-positive oropharyngeal cancer. Br J Cancer. 2014;110(2):489-500.
28. Prestwich RJ, Errington F, Hatfeld P, et al. Te immune system-is it relevant to cancer development, progression and treatment? Clin Oncol (R Coll Radiol). 2008;20(2):101-112.